Tanezumab ' s Phase 3 Results: A Promising Sign For Non-Opioid Pain Treatments
As the opioid crisis has unfolded concerns have grown about dependency and the potentially addictive nature of opioid-based pain treatments. Having satisfactory non-opioid treatment alternatives will need to be an integral part of effective pain management.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Source Type: news